CPA Submits Section 232 Comments Supporting a Polysilicon Tariff-Rate Quota (TRQ)

CPA Submits Section 232 Comments Supporting a Polysilicon Tariff-Rate Quota (TRQ)

The domestic polysilicon supply remains a national security imperative for the United States for many reasons including: China’s link to forced labor and human rights abuses; a globalized Chinese Communist Party-subsidized solar industry leading to overcapacity and export dumping; and the limitations of U.S. trade remedies to help, deep into the solar supply chain.

CPA Supports U.S. Department of Commerce Investigations of Solar Trade Violations in Indonesia, Laos, & India

CPA Supports U.S. Department of Commerce Investigations of Solar Trade Violations in Indonesia, Laos, & India

Investigation follows formal petitions filed last month by The Alliance for American Solar Manufacturing and Trade, in response to market manipulation driven by predominantly Chinese-owned manufacturing companies operating in Indonesia, and Laos, as well as those headquartered in India.

CPA Applauds President Trump for Closing De Minimis Loophole Permanently

CPA Applauds President Trump for Closing De Minimis Loophole Permanently

Closing de minimis means that commercial shipments from overseas vendors must enter the United States through standard customs procedures, submit full import documentation, and pay applicable duties and taxes—a long-overdue reform to restore order and accountability to America’s trade system.

Toomey: Federal Procurement Can Incentivize New U.S. Pharmaceutical Production

Toomey: Federal Procurement Can Incentivize New U.S. Pharmaceutical Production

The United States has become incredibly dependent on imports to meet its daily pharmaceutical needs. This heavy reliance on imports is now creating serious drug shortages and has led to a flurry of safety concerns.

CPA Supports Measures To Curb Trade Imbalances Caused By Overvalued Dollar

CPA Supports Measures To Curb Trade Imbalances Caused By Overvalued Dollar

Realigning the dollar would be the most comprehensive and effective move to address the U.S. competitive disadvantage. It can be done either by a multilateral intervention agreement, or a MAC, which would be a federal tool to moderate foreign investment in dollar financial assets.

Restoring America’s Generic Drug Independence

Restoring America’s Generic Drug Independence

America’s generic drug supply is at a crisis point. As detailed in previous reports, the United States is dangerously reliant on a high-risk imported drug supply, and today’s widespread drug shortages stem not from shipping delays or unexpected demand—but from a collapse in domestic production.